Navigation Links
InspireMD Reports Financial Results for Quarter Ended September 30, 2013
Date:11/11/2013

BOSTON, Nov. 11, 2013 /PRNewswire/ -- InspireMD Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, today announced financial results for the quarter ended September 30, 2013.

Key Highlights of Recent Events

  • MGuard™ outperformed bare metal and drug eluting stents in all-cause mortality in STEMI patients for the 12-month follow-up data from the MASTER Trial
  • Secured $10 million in venture debt financing to support product development and clinical expansion
  • Initiated direct selling activities in Germany
  • Upcoming Near-term Milestones

  • Expanding direct selling organization and activities in other key European countries
  • Accelerating product development and clinical programs to expand the MicroNet therapeutic platform to a drug eluting stent, as well as for carotid and peripheral artery
  • CGuard™ first in man carotid stent trial initiation planned for Q1 2014
  • "The positive mortality data from the MASTER trial 12-month follow-up is being well received by physicians since the results were announced at the TCT conference just two weeks ago.  We believe this data will be an important factor in our efforts to increase adoption rates for the MGuard and for recruitment in the MASTER II trial," stated Alan Milinazzo, President and Chief Executive Officer of InspireMD.  "The acute benefits reported with the MGuard in ST segment resolution, improved TIMI flow and reduced infarct size, gives us the confidence that these improved clinical results are achieved due to the embolic protection benefits of our MicroNet technology."

    "Encouraged by the MASTER trial 12-month data, we believe there is significant potential for our platform technology, MicroNet, to support a broader pipeline of devices in the coronary and vascular setting. We recently put into place a financing strategy that off
    '/>"/>

    SOURCE InspireMD
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. InspireMD Announces First Quarter 2012 Financial Results
    2. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
    3. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
    4. InspireMD to Present at Harvard Investors Group on June 27 in New York
    5. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
    6. InspireMD Reports Results For Period Ending Sept. 30, 2012
    7. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
    8. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
    9. InspireMD Reports Results for Period Ended Dec. 31, 2012
    10. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
    11. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... ATLANTA , Jan. 23, 2015 More than a ... a quarter of those with private insurance, filled a prescription ... to a report in this week,s Morbidity and Mortality Weekly ... health care providers to treat moderate to severe pain.  They ...
    (Date:1/23/2015)... , Jan. 23, 2015  Now available for sale, ... 7,849,611) support that prevents ankle sprains by cushioning the ... it fits securely around the outside of any shoe ... & comfort while still offering protection against sprains. With ...
    (Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
    Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
    ... of the Results, ISTA Plans to Initiate,Phase III Studies ... 31, 2007 /PRNewswire-FirstCall/ -- ISTA,Pharmaceuticals, Inc. , today announced ... IIb clinical study of,ecabet sodium, which is being developed ... ecabet sodium group achieved a strong,trend in the objective ...
    ... /PRNewswire-FirstCall/ - Research,collaborators with Oncolytics Biotech Inc. ... covering REOLYSIN(R),clinical trial data at the American ... be held June 1-5, 2007 in Chicago. ... Phase I systemic,administration trial. , The poster, ...
    Cached Medicine Technology:ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 2ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 3ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 4ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 5Oncolytics Biotech Inc.'s Research Collaborators to Present,REOLYSIN Clinical Trial Data at ASCO Conference 2
    (Date:1/22/2015)... a famous wedding dress company offering many trendy designs. Today, ... Twitter, and Pinterest. The fans will have an opportunity to ... week. , Moreover, the company has extended its 2015 New ... for more information. , Angelweddingdress is a famous ...
    (Date:1/22/2015)... TX (PRWEB) January 22, 2015 A ... issue of experience and person-centeredness in the long-term care ... towards action across the continuum. The paper, “The Power ... Continuum,” engages perspectives and practices of the patient, resident ...
    (Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved ... upcoming 32nd Annual Miami Breast Cancer Conference ... LLC (PER®) , shares that “a fast-growing, virulent” cancer ... she had not followed up her clean mammogram with ...
    (Date:1/22/2015)... Four years since the release of their debut recording Love is ... Avasa & Matthew Love – the duo are pleased to announce ... White Swan Records on February 24, 2015. , THE ROAD offers ... to all of us to walk out of the mire of ...
    (Date:1/22/2015)... January 22, 2015 Compare-autoinsurance.org has released a new ... by an auto insurance policy . , Some types ... Clients should check the newly released blog post to see if ... and dangerously damaged vehicles are some of the cars that cannot ...
    Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
    ... one day serve as an alternative to steroid medications and ... on research findings at the Salk Institute for Biological Studies. ... in Salk,s Laboratory of Genetics and Ronald M. Evans, the ... that defends the body against cancer also plays a key ...
    ... CA -- As many as 10 million American women ... and urinary tract difficulties and infertility due to endometriosis, ... lining of the uterus the endometrium begin ... This year,s annual meeting of gynecologic laparoscopic surgeons ...
    ... sun can give rise to skin cancer has increased, so ... can give rise to contact allergy when exposed to the ... skin allergy. Scientists at the University of Gothenburg and Chalmers ... UV filter that does not have undesired effects., , "Unfortunately, ...
    ... News) -- Researchers have identified a gene variation that ... at which men experience an age-related decline in intellectual ... pilots over the age of 40 who took a ... two years. The participants included recreational pilots, certified flight ...
    ... ORLANDO, Fla. October 25, 2011 Researchers at Tenon ... disease whose vision improved after cataract surgery also showed ... behaviors. Lead researcher Brigitte Girard, MD, will discuss her ... 2011 Annual Meeting. This is the first study ...
    ... Heart and Stroke Foundation study has found that women under ... heart attack and their health status declines more than ... AMI55 study found that women between the ages of 20 ... chest pain, and worse quality of life than men one ...
    Cached Medicine News:Health News:New anti-inflammatory drugs might help avoid side effects of steroids 2Health News:New anti-inflammatory drugs might help avoid side effects of steroids 3Health News:Close-up on endometriosis at 40th AAGL Global Congress 2Health News:Close-up on endometriosis at 40th AAGL Global Congress 3Health News:Close-up on endometriosis at 40th AAGL Global Congress 4Health News:A substance from bacteria can lead to allergy-free sunscreen 2Health News:Aging Brain's Decline May Hinge on a Gene 2Health News:Mood, cognition and sleep patterns improve in Alzheimer's patients after cataract surgery 2Health News:Quality-of-life for women an issue: in some matters of the heart, women do not fare as well as men 2
    Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
    Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
    Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
    Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
    Medicine Products: